Cargando…

Predictor of multidrug resistant tuberculosis in southwestern part of Ethiopia: a case control study

BACKGROUND: Curable disease tuberculosis is becoming incurable or difficult to treat due to drug resistance. Multi drug resistance tuberculosis is a major health problem for less developed countries. Development of drug resistance is mainly as result of man related factors and poor lifestyle. Identi...

Descripción completa

Detalles Bibliográficos
Autores principales: Gobena, Dabesa, Ameya, Gemechu, Haile, Kinfe, Abreha, Getaneh, Worku, Yoseph, Debela, Tessema
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029339/
https://www.ncbi.nlm.nih.gov/pubmed/29970076
http://dx.doi.org/10.1186/s12941-018-0283-8
_version_ 1783336939518164992
author Gobena, Dabesa
Ameya, Gemechu
Haile, Kinfe
Abreha, Getaneh
Worku, Yoseph
Debela, Tessema
author_facet Gobena, Dabesa
Ameya, Gemechu
Haile, Kinfe
Abreha, Getaneh
Worku, Yoseph
Debela, Tessema
author_sort Gobena, Dabesa
collection PubMed
description BACKGROUND: Curable disease tuberculosis is becoming incurable or difficult to treat due to drug resistance. Multi drug resistance tuberculosis is a major health problem for less developed countries. Development of drug resistance is mainly as result of man related factors and poor lifestyle. Identifying predictors of drug resistance and working on them is the important way of reducing the expansion in high burden countries. Ethiopia is one of TB, TB/HIV, and multi-drug resistant tuberculosis (MDR-TB) high burden country globally. This study was aimed to assess predictor of MDR-TB in southwest part of Ethiopia. METHODS: Unmatched case control study was conducted in case to control ratio of 1:1.2 in southwest part of Ethiopia. The cases were recruited from confirmed MDR-TB patient enrolled on second line treatment in Shenen Gibe Hospital (MDR-TB treatment center of the prefecture) and the controls were recruited from previously TB patients who cured or patient with smear negative at the end of treatment month during the study period in the same area. The data was collected by structured questionnaire by interview and logistic regression analyses were used to identify predictors of MDR-TB. Odds ratios with 95% CI were computed to determine the predictors. RESULT: From the total 132 participants about 45% of them were cases. None disclosed tuberculosis infected to relatives [AOR = 3.4, 95% CI (1.2–9.8)], insufficient instruction on how to take anti-TB drug [AOR = 4.7, 95% CI (1.4–14.6)], contact history with MDR-TB [AOR = 8.5, 95% CI (2.9–25.5)], interruption of first-line anti-TB treatment for at list 1 day [AOR = 7.9, 95% CI (2.5–24.9)], and having alcohol drinking habits [AOR = 5.1, 95% CI (1.4–18.7)] were identified predictors for MDR-TB infection in study area. CONCLUSION: TB infection disclosure status, insufficient instruction on drug usage, contact history with MDR-TB, interruption of first-line anti-TB drugs, and alcohol drinking habits were identified predictor of MDR-TB case. Therefore, early detection and proper treatment of drug susceptible TB, strengthening directly observed treatment, short-course on daily bases, community involvement, and supporting the patient to intervene identified factors is paramount.
format Online
Article
Text
id pubmed-6029339
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-60293392018-07-09 Predictor of multidrug resistant tuberculosis in southwestern part of Ethiopia: a case control study Gobena, Dabesa Ameya, Gemechu Haile, Kinfe Abreha, Getaneh Worku, Yoseph Debela, Tessema Ann Clin Microbiol Antimicrob Research BACKGROUND: Curable disease tuberculosis is becoming incurable or difficult to treat due to drug resistance. Multi drug resistance tuberculosis is a major health problem for less developed countries. Development of drug resistance is mainly as result of man related factors and poor lifestyle. Identifying predictors of drug resistance and working on them is the important way of reducing the expansion in high burden countries. Ethiopia is one of TB, TB/HIV, and multi-drug resistant tuberculosis (MDR-TB) high burden country globally. This study was aimed to assess predictor of MDR-TB in southwest part of Ethiopia. METHODS: Unmatched case control study was conducted in case to control ratio of 1:1.2 in southwest part of Ethiopia. The cases were recruited from confirmed MDR-TB patient enrolled on second line treatment in Shenen Gibe Hospital (MDR-TB treatment center of the prefecture) and the controls were recruited from previously TB patients who cured or patient with smear negative at the end of treatment month during the study period in the same area. The data was collected by structured questionnaire by interview and logistic regression analyses were used to identify predictors of MDR-TB. Odds ratios with 95% CI were computed to determine the predictors. RESULT: From the total 132 participants about 45% of them were cases. None disclosed tuberculosis infected to relatives [AOR = 3.4, 95% CI (1.2–9.8)], insufficient instruction on how to take anti-TB drug [AOR = 4.7, 95% CI (1.4–14.6)], contact history with MDR-TB [AOR = 8.5, 95% CI (2.9–25.5)], interruption of first-line anti-TB treatment for at list 1 day [AOR = 7.9, 95% CI (2.5–24.9)], and having alcohol drinking habits [AOR = 5.1, 95% CI (1.4–18.7)] were identified predictors for MDR-TB infection in study area. CONCLUSION: TB infection disclosure status, insufficient instruction on drug usage, contact history with MDR-TB, interruption of first-line anti-TB drugs, and alcohol drinking habits were identified predictor of MDR-TB case. Therefore, early detection and proper treatment of drug susceptible TB, strengthening directly observed treatment, short-course on daily bases, community involvement, and supporting the patient to intervene identified factors is paramount. BioMed Central 2018-07-03 /pmc/articles/PMC6029339/ /pubmed/29970076 http://dx.doi.org/10.1186/s12941-018-0283-8 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Gobena, Dabesa
Ameya, Gemechu
Haile, Kinfe
Abreha, Getaneh
Worku, Yoseph
Debela, Tessema
Predictor of multidrug resistant tuberculosis in southwestern part of Ethiopia: a case control study
title Predictor of multidrug resistant tuberculosis in southwestern part of Ethiopia: a case control study
title_full Predictor of multidrug resistant tuberculosis in southwestern part of Ethiopia: a case control study
title_fullStr Predictor of multidrug resistant tuberculosis in southwestern part of Ethiopia: a case control study
title_full_unstemmed Predictor of multidrug resistant tuberculosis in southwestern part of Ethiopia: a case control study
title_short Predictor of multidrug resistant tuberculosis in southwestern part of Ethiopia: a case control study
title_sort predictor of multidrug resistant tuberculosis in southwestern part of ethiopia: a case control study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029339/
https://www.ncbi.nlm.nih.gov/pubmed/29970076
http://dx.doi.org/10.1186/s12941-018-0283-8
work_keys_str_mv AT gobenadabesa predictorofmultidrugresistanttuberculosisinsouthwesternpartofethiopiaacasecontrolstudy
AT ameyagemechu predictorofmultidrugresistanttuberculosisinsouthwesternpartofethiopiaacasecontrolstudy
AT hailekinfe predictorofmultidrugresistanttuberculosisinsouthwesternpartofethiopiaacasecontrolstudy
AT abrehagetaneh predictorofmultidrugresistanttuberculosisinsouthwesternpartofethiopiaacasecontrolstudy
AT workuyoseph predictorofmultidrugresistanttuberculosisinsouthwesternpartofethiopiaacasecontrolstudy
AT debelatessema predictorofmultidrugresistanttuberculosisinsouthwesternpartofethiopiaacasecontrolstudy